FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/098921 [Registered on: 11/12/2025] Trial Registered Prospectively
Last Modified On:
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Cosmetic]  
Study Design  Single Arm Study 
Public Title of Study   A study to check if a skin care product is safe and helps reduce signs of ageing 
Scientific Title of Study   To evaluate the safety and efficacy of a Skin care formulation in terms of antiaging reduction in fine lines and wrinkles, reduction in pigmentary patches, skin firmness, skin homogeneity and skin moisturisation on healthy human subjects. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
XXX-RF03-XC-NR25; Version: 01; Dated: 19/11/2025  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Niharika Salian 
Designation  Principal Investigator 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra

Mumbai
MAHARASHTRA
400025
India 
Phone  02243349191  
Fax    
Email  niharika@mascotspincontrol.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Niharika Salian 
Designation  Principal Investigator 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra


MAHARASHTRA
400025
India 
Phone  02243349191  
Fax    
Email  niharika@mascotspincontrol.in  
 
Details of Contact Person
Public Query
 
Name  Dr Mohit Lalvani 
Designation  Study Director 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra

Mumbai
MAHARASHTRA
400025
India 
Phone  02243349191  
Fax    
Email  mohit.CTRI@gmail.com  
 
Source of Monetary or Material Support  
VLCC Personal Care Ltd. Magnum City Centre, Near Birla Navya Township, Sector-63A, Gurugram, Haryana 122011  
 
Primary Sponsor  
Name  VLCC Personal Care Ltd.  
Address  Magnum City Centre, Near Birla Navya Township, Sector-63A, Gurugram, Haryana 122011  
Type of Sponsor  Other [Personal Care or Beauty Industry] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  NA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Niharika Salian  Mascot Spincontrol India Pvt. Ltd.   Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra
Mumbai
MAHARASHTRA 
02243349191

niharika@mascotspincontrol.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethos- Institutional Ethics committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  having crow’s feet, under eye, forehead and nasolabial wrinkles and fine lines, having dull skin, having dark spots and patchy skin 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Nil  NA 
Intervention  VLCLBOTOFLESRM628  The Product is applied on Whole face two times in a day for the period of 84 days. 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  1)Indian male and Female subjects
2)Healthy subjects
3)Skin is healthy on the studied anatomic unit
4)Having crows feet, under eye, forehead and nasolabial wrinkles and fine lines, having dull skin, having dark spots and patchy skin
 
 
ExclusionCriteria 
Details  1)For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
2)Having refused to give his/her assent by not signing the consent form
3)Taking part in another study liable to interfere with this study
4)Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months)
5)Having acne prone skin.
6)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
7)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products.
8)Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
9)Having cutaneous hypersensitivity.
10)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
11)Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit.
12)Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted)
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Reduction in fine lines and wrinkles, reduction in pigmentary patches, skin firmness, skin homogeneity and skin moisturisation   Baseline, Day 14, Day28, Day 42, Day56, Day 70 and Day 84 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  NA 
 
Target Sample Size   Total Sample Size="36"
Sample Size from India="36" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   21/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="5"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

OBJECTIVE:The objective of this study will be to evaluate the safety & efficacy of a Skin care formulation in terms of antiaging reduction in fine lines and wrinkles, reduction in pigmentary patches, skin firmness, skin homogeneity and skin moisturisation on healthy human subjects.

 

The evaluation will be performed using:Subject Self Evaluation, Dermatological Evaluation: Cosmetic Acceptability, Dermatological Evaluation: Efficacy, Cutometry, Spectrophotometry, Corneometry, Mexametry

 

POPULATION:36 (18 male & 18 female) human subjects will be selected for the study.

The subjects selected for this study will be healthy male & females, aged between 25 to 55 years, having crow’s feet, under eye, forehead and nasolabial wrinkles and fine lines, having dull skin, having dark spots and patchy skin.

 

STUDY DURATION: 84 days following the first application of the product.

 
Close